Why the study?
What are the predictors of early and late stroke following TAVR with a self-expanding bioprosthesis?
Population
Patients enrolled in the CoreValve US Extreme Risk and High Risk Pivotal Trials or Continued Access Study
Design
Cohort
Follow-up
1 year
Authors
Loading...
May inform TAVR patient selection and technique; leaves open prospective validation of targeted prevention.
What are the predictors of early and late stroke following TAVR with a self-expanding bioprosthesis?
Early stroke after TAVR is predicted by clinical and procedural factors, whereas late stroke is predicted by patient characteristics, highlighting the need for refined patient selection and procedural management.
Kleiman et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: